|
Nplate etc
It is quite encouraging to hear of such good responses that mcgill54 and Birgitta have had. Here's hoping for a very long durable response. Just for anyone interested with very low platelets and no other options, the NIH has started recruiting for their trial with Promacta in low risk MDS patients.
__________________
possible low to int-1 MDS with predominant thrombocytopenia, mild anemia, dx 7/08, in watch and wait mode
|